CVS HEALTH CORPORATION (CVS) FY2026 Q1 P&L / Income Statement
2026-01-01 to 2026-03-31
Revenue by Product and Service
2026-01-01 to 2026-03-31
Swipe to see the full flow
Chart details
CVS HEALTH CORPORATION (CVS) FY2026 Q1 P&L / Income Statement
Income statement for 2026-01-01 through 2026-03-31. View: Revenue categories. Revenue uses this breakdown; costs and expenses retain the consolidated categories.
- Total revenues
- 100,426,000,000 US dollars
- Total operating costs
- 95,746,000,000 US dollars
- Operating income
- 4,680,000,000 US dollars
- Other income (expense), net (calculated)
- negative 742,000,000 US dollars
- Income before income tax provision
- 3,938,000,000 US dollars
- Income tax provision
- 981,000,000 US dollars
- Net income
- 2,957,000,000 US dollars
- Products
- 62,226,000,000 US dollars
- Services
- 3,835,000,000 US dollars
- Premiums
- 33,791,000,000 US dollars
- Net investment income
- 574,000,000 US dollars
- Cost of products sold
- 55,444,000,000 US dollars
- Health care costs
- 29,358,000,000 US dollars
- Operating expenses
- 10,944,000,000 US dollars
Chart connections
- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to CVS HEALTH CORPORATION: $2.94 B; to noncontrolling interests: $14.00 M.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Operating margin
4.7%
Operating profit / revenue
Cash conversion
143.7%
Operating cash / net income, same period
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
